Made progress deploying all components of the Nanox solution including Nanox.ARC and Nanox.AI Expanded US sales and support staff a…
New seven-part series explores disparities in care, funding and innovation impacting half the world's population LONDON, Nov. 21, 2024 /PRNewswire/…
The $16M USD round was led by Celesta Capital, with participation from Tenacity Ventures, Cedars Sinai; OneCell to continue transforming…
TEL AVIV, Israel, Nov. 20, 2024 /PRNewswire/ -- Converge Bio, a generative AI platform for accelerated drug discovery and development, today…
"Senolytic Immunotherapy" is the basis of Immorta Bio's first-in-class oncology platform MIAMI BEACH, Fla., Nov. 20, 2024 /PRNewswire/ -- A…
Grant funding will support the new Syn-Q Clinical Study to further investigate the quantification of P-SYN in skin biopsies using CND's…
PHILADELPHIA, Nov. 20, 2024 /PRNewswire/ -- PolicyMap, an online data and mapping company, announced today the integration of Surgo Health's' Granular…
Program to provide investigational drug to ALS patients who would otherwise be ineligible for clinical trials SANTA CLARA, Calif., Nov.…
NAPLES, FL / ACCESSWIRE / November 20, 2024 / Stemtech Corporation (OTCQB:STEK) and Seacret Direct, LLC (doing business as VIÁGO)…
Potential to redefine frontline AML treatment being evaluated in clinic: Mipletamig, CD3 x CD123 bispecific, in combination with standard of…